Literature DB >> 25798679

Prognostic significance of liver parameters at 1-year follow-up in children and adults undergoing myeloablative allogeneic stem cell transplantation.

K Jordan1, I J Christensen2, M H Jørgensen3, C Heilmann3, H Sengeløv4, K G Müller1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25798679     DOI： 10.1038/bmt.2015.54

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  8 in total

Review 1.  Review article: management of hepatic disease following haematopoietic cell transplant.

Authors:  G B McDonald
Journal:  Aliment Pharmacol Ther       Date:  2006-08-01       Impact factor: 8.171

2.  Hyperbilirubinemia after hematopoietic stem cell transplantation: comparison of clinical and pathologic findings in 41 autopsied cases.

Authors:  Yuki Kagoya; Tsuyoshi Takahashi; Yasuhito Nannya; Aya Shinozaki; Satoshi Ota; Masashi Fukayama; Mineo Kurokawa
Journal:  Clin Transplant       Date:  2011-09-15       Impact factor: 2.863

3.  Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?

Authors:  John T Horan; Brent R Logan; Manza-A Agovi-Johnson; Hillard M Lazarus; Andrea A Bacigalupo; Karen K Ballen; Christopher N Bredeson; Matthew H Carabasi; Vikas Gupta; Gregory A Hale; Hanna Jean Khoury; Mark B Juckett; Mark R Litzow; Rodrigo Martino; Philip L McCarthy; Franklin O Smith; J Douglas Rizzo; Marcelo C Pasquini
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

Review 4.  Biomarkers of regimen-related mucosal injury.

Authors:  Rachel J Gibson; Joanne M Bowen
Journal:  Cancer Treat Rev       Date:  2011-10       Impact factor: 12.111

Review 5.  Implications of treatment-induced mucosal barrier injury.

Authors:  Nicole M A Blijlevens
Journal:  Curr Opin Oncol       Date:  2005-11       Impact factor: 3.645

6.  Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients.

Authors:  N M A Blijlevens; J P Donnelly; B E DePauw
Journal:  Bone Marrow Transplant       Date:  2005-10       Impact factor: 5.483

Review 7.  Graft-versus-host disease.

Authors:  James L M Ferrara; John E Levine; Pavan Reddy; Ernst Holler
Journal:  Lancet       Date:  2009-03-11       Impact factor: 79.321

8.  Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation.

Authors:  Walter J F M van der Velden; Alexandra H E Herbers; Ton Feuth; Nicolaas P M Schaap; J Peter Donnelly; Nicole M A Blijlevens
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.